Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy

Multiple myeloma (MM) is a neoplasm of plasma cells within the bone marrow. A major impact on improving survival in MM has been the use of the boronic acid-derived proteasome inhibitor bortezomib, a first-in-class selective inhibitor of the 26S proteasome. Ocular side effects of bortezomib are rare....

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Charles, Mukhi, Nikhil, Kremer, Valerie, Shinder, Roman, Verma, Vaibhav, Olcay, Batuman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2015
Materias:
Case-Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508549/
https://www.ncbi.nlm.nih.gov/pubmed/26330998
http://dx.doi.org/10.4081/hr.2015.5729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508549/
https://www.ncbi.nlm.nih.gov/pubmed/26330998
http://dx.doi.org/10.4081/hr.2015.5729

Ejemplares similares